Muscle growth research measures several related but different outcomes, including fat-free mass, lean tissue, skeletal muscle mass, muscle-fiber cross-sectional area and strength. The statistics below cover resistance-training trials, protein and creatine supplementation, training loads, frequency, aging and sarcopenia, with each population and measurement period stated explicitly.
Key Muscle Growth Statistics
The most broadly useful figures include:
- 1.53 kg was the average increase in combined fat-free, lean and skeletal muscle mass in resistance-training interventions involving healthy adult males.
- The 95% confidence interval for that pooled muscle-mass increase was 1.30–1.76 kg in the included healthy-adult-male trials.
- Protein supplementation added 0.30 kg of fat-free mass during prolonged resistance exercise training in healthy adults.
- Protein supplementation added 2.49 kg of one-repetition-maximum strength during prolonged resistance exercise training in healthy adults.
- Protein supplementation increased muscle-fiber cross-sectional area by 310 µm² during prolonged resistance training in healthy adults.
- Protein supplementation increased mid-femur cross-sectional area by 7.2 mm² during prolonged resistance training in healthy adults.
- Protein supplementation produced a 1.05 kg fat-free-mass difference in resistance-trained adults during prolonged resistance training.
- Protein intakes above 1.62 g/kg/day produced no additional fat-free-mass gain in the reported prolonged-training meta-regression of healthy adults.
- Protein above the RDA increased lean mass by 0.77 kg versus the RDA in the resistance-training subgroup of apparently healthy adults aged 19 and older.
- Creatine plus resistance training increased lean tissue mass by 1.37 kg versus placebo plus training in older adults with mean study ages of 57–70 years.
- The creatine review included 22 studies and 721 participants in older-adult resistance-training interventions lasting 7–52 weeks.
- Higher-load, multiset, twice-weekly training had a hypertrophy SMD of 0.66 versus non-exercising control in healthy adults in a Bayesian network meta-analysis.
- Network-estimated hypertrophy effects ranged from SMD 0.10 to 0.66 across resistance-training prescriptions in healthy adults.
- The global sarcopenia prevalence estimate was 10% under EWGSOP2 criteria in studies conducted from 2000–2019.
- The same global sarcopenia review estimated 27% prevalence under its overall muscle-mass definition in studies conducted from 2000–2019.
- Sarcopenia prevalence ranged from 0.2% to 86.5% across individual studies and classifications in global adult populations studied from 2000–2019.
- Protein supplementation produced a 13.5 kg weighted mean difference in 1RM leg-press strength after more than 6 weeks of resistance training in younger and older adults.
- Post-exercise protein was associated with a 0.54 kg fat-free-mass advantage versus placebo in adults undergoing resistance training in trials included through May 1, 2023.
Contents
- Key Muscle Growth Statistics
- Resistance Training Muscle Growth Statistics
- Muscle Hypertrophy Data by Training Load
- Protein Intake and Muscle Growth Statistics
- Creatine and Muscle Growth Statistics in Older Adults
- Muscle Growth, Aging and Sarcopenia Statistics
- Training Frequency, Strength and Muscle Growth Data
Resistance Training Muscle Growth Statistics
A systematic review of resistance training in healthy adult males pooled fat-free mass, lean muscle mass and skeletal muscle mass because studies used different body-composition outcomes. Across the training interventions in the included trials, the average combined increase was 1.53 kg, with a 95% confidence interval of 1.30–1.76 kg.
The review reported I² = 0% for heterogeneity in that pooled muscle-mass effect. This is a study-level meta-analytic result, not a guarantee for every trainee, and the combined outcomes are not interchangeable measurements of contractile muscle.
Protein supplementation research provides a second benchmark for prolonged resistance exercise. The relevant review included 1,863 participants across 49 randomized studies lasting at least 6 weeks, and found an average 0.30 kg fat-free-mass advantage over control supplementation, with a 95% confidence interval of 0.09–0.52 kg.
The same review found a 2.49 kg average advantage in one-repetition-maximum strength, with a 95% confidence interval of 0.64–4.33 kg. Strength and fat-free mass are related outcomes, but the 1RM result should not be presented as a direct measure of muscle size.
Muscle Hypertrophy Data by Training Load
Load-comparison research separates resistance training into four categories. The definitions below combine percentage of one-repetition maximum with repetition ranges used to group the studies.
| Training-load category | Definition used in the review |
|---|---|
| Very low load | Below 30% of 1RM or above 35 repetitions per set |
| Low load | 30–59% of 1RM or 16–35 repetitions per set |
| Moderate load | 60–79% of 1RM or 8–15 repetitions per set |
| High load | At least 80% of 1RM or no more than 7 repetitions per set |
In pooled strength comparisons, high loads had an advantage over low loads and moderate loads for 1RM strength, while moderate loads had an advantage over low loads. These findings concern strength rather than hypertrophy, so they should not be treated as proof that the strongest load category always produces the largest muscle gain.
A Bayesian network meta-analysis estimated hypertrophy effects against non-exercising control across combinations of load, sets and weekly frequency. The largest reported estimate was SMD 0.66 for higher-load, multiset, twice-weekly training, with a 95% credible interval of 0.47–0.85.
Across all resistance-training prescriptions, network-estimated hypertrophy SMDs ranged from 0.10 to 0.66. Higher-load single-set training had an SMD of 0.40 once weekly, with a 95% credible interval of −0.35 to 1.17, and 0.10 twice weekly, with a 95% credible interval of −0.57 to 0.80; both intervals crossed zero.
Protein Intake and Muscle Growth Statistics
Protein-related muscle outcomes vary by measurement method and training status. During prolonged resistance training, supplementation increased muscle-fiber cross-sectional area by 310 µm² on average, with a 95% confidence interval of 51–570 µm².
It also increased mid-femur cross-sectional area by 7.2 mm², with a 95% confidence interval of 0.20–14.30 mm². The first is a muscle-fiber measure and the second is an anatomical measure, so neither should be read as a whole-body muscle-mass estimate.
| Population or analysis | Fat-free or lean-mass result | Measurement context |
|---|---|---|
| Resistance-trained adults | 1.05 kg difference | 95% CI: 0.61–1.50 kg |
| Untrained adults | 0.15 kg difference | Reported subgroup result; not statistically significant |
| Above-RDA protein, all included conditions | 0.32 kg versus RDA | 22 comparisons; studies through August 2018 |
| Above-RDA protein, resistance-training subgroup | 0.77 kg versus RDA | 95% CI: 0.23–1.31 kg; three comparisons |
| Above-RDA protein, non-stressed subgroup | 0.08 kg versus RDA | 95% CI: −0.59 to 0.75 kg |
The protein-supplementation meta-regression reported that the fat-free-mass effect declined by 0.01 kg per year of increasing study age, with a 95% confidence interval from −0.02 to approximately 0.00 kg per year. This is a study-level association, not an individual aging trajectory.
The same analysis estimated no additional fat-free-mass gain above 1.62 g/kg/day in its protein-intake breakpoint model. That threshold is a model estimate from the included prolonged-training studies, not a universal intake target.
A separate review of apparently healthy adults aged 19 and older found that protein above the RDA improved lean-mass change by 0.32 kg versus the RDA across 22 comparisons, with a 95% confidence interval of 0.01–0.64 kg. The pooled comparisons included resistance training, energy restriction and non-stressed conditions, so the overall result is broader than a resistance-training-only estimate.
Creatine and Muscle Growth Statistics in Older Adults
Creatine evidence in this dataset specifically concerns older adults performing resistance training. A meta-analysis of 22 studies and 721 participants covered interventions lasting 7–52 weeks, with included programs generally training 2–3 days per week.
Creatine plus resistance training increased lean tissue mass by 1.37 kg versus placebo plus training, with a 95% confidence interval of 0.97–1.76 kg. The mean study ages were 57–70 years, and lean tissue is not identical to contractile muscle.
The same review found strength differences for two exercises:
- Chest-press strength improved with an SMD of 0.35, with a 95% confidence interval of 0.16–0.53.
- Leg-press strength improved with an SMD of 0.24, with a 95% confidence interval of 0.05–0.43.
These are strength outcomes rather than muscle-mass outcomes. The study-duration range describes the included interventions and is not a recommended supplementation or training duration.
Muscle Growth, Aging and Sarcopenia Statistics
Sarcopenia prevalence is highly dependent on the definition, population, measurement instrument and cutoff used. A global systematic review of studies conducted from 2000–2019 estimated overall prevalence at 10% under EWGSOP2 criteria and 27% under its overall muscle-mass definition.
| Classification or population | Reported prevalence range | Scope |
|---|---|---|
| All included classifications | 0.2–86.5% | Individual global studies |
| Women | 0.3–91.2% | Included studies; not a pooled sex-specific estimate |
| Men | 0.4–87.7% | Included studies; not a pooled sex-specific estimate |
| EWGSOP-defined | 0.4–57.4% | Studies using EWGSOP |
| AWGS-defined | 0.3–53.0% | Studies using AWGS |
| Severe sarcopenia, overall | 0.2–34.4% | 34 studies reporting severe sarcopenia |
| Severe sarcopenia, women | 0.2–45.0% | Subset reporting severe sarcopenia |
| Severe sarcopenia, men | 0.2–17.1% | Subset reporting severe sarcopenia |
The wide ranges are not contradictory measurements of one fixed global rate. They reflect differences in age structure, health status, diagnostic criteria, cutoffs and instruments, so the pooled estimates and study-level ranges should remain clearly separated.
Source: Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis.
Training Frequency, Strength and Muscle Growth Data
A frequency review compared training a muscle group 1–3 days per week on a volume-equated basis in healthy adults without chronic disease or injury, using trials lasting at least 4 weeks. This design helps separate frequency from total training volume, but the comparison itself is a study framework rather than a single growth estimate.
Source: Effects of Resistance Training Frequency on Measures of Muscle Hypertrophy.
Protein supplementation studies also report measurable strength and fat-free-mass outcomes after more than 6 weeks of resistance training. In a pooled analysis of 22 randomized trials involving younger and older adults, supplementation was associated with a 13.5 kg weighted mean difference in 1RM leg-press strength and a 0.69 kg fat-free-mass gain versus placebo.
A network meta-analysis covering 116 trials and 4,711 participants, with searches through May 1, 2023, examined protein timing and protein type in adults undergoing resistance training. Post-exercise protein was associated with a 0.54 kg fat-free-mass advantage versus placebo; the review characterized selected outcomes as moderate-certainty estimates, while its physical-performance outcomes did not show significant enhancement from timing or type.
The figures across these studies should be read as estimates for defined trial populations and periods. Fat-free mass, lean tissue, skeletal muscle mass, cross-sectional area, hypertrophy SMDs and strength are complementary outcomes, not interchangeable measures of muscle growth.